Clinical trial
Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals…
NCT00307203 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00307203 |
|---|---|
| Title | Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke |
| Official title | Nicotine and Smoking Cessation in Schizophrenia |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tobacco-Use Disorder, Schizophrenia, Psychotic Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | bupropion SR, Cognitive Behavioral Group Therapy, nicotine replacement therapy |
| Enrollment | 51 |
| Start date | Aug 1, 1998 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 1, 2004 |
| First posted | Mar 27, 2006 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: